Alexion Pharmaceuticals
Boston, US · 3 known investors
Alexion is a biopharmaceutical company focused on researching and developing treatments for rare diseases, investigating new targets, modalities and technologies to address patient needs globally.
Investors · 3
Acquisitions · 2
Early investors' stakes continue via these dealsSynageva BioPharma Corp.
Developed therapies for rare conditions with unmet medical needs; exited via IPO and acquired by Alexion Pharmaceuticals.
Syntimmune
Acquired by Alexion Pharmaceuticals